Skip to content

英格雷顿

US · INGR #1925 按市值排名 上市于 1970
97.93 +0.66 +0.68%
实时 - 追踪5344个代码 - 心跳于8秒前 · 2026-10-16 19:30

✦ 量化股权信号 计算方式说明

增持
  • 最近一期(2026/Q3)披露持股的机构数量减少了1家。
  • 机构持股总比例上升了0.2个百分点。

机构持股

机构持股比例
99.49% +0.18pp
机构数量
699 -1
数据截至
2026/Q3 较上一报告期

持股变动 vs 资金流向

方向分歧

机构在上一报告期增持了股份,同时该股在最近20个交易日的主力资金呈净流出——两者方向出现分歧。

机构持股变动数据按季度发布且存在滞后;资金流向数据为每日更新。请将其作为方向性的交叉验证参考,而非精确的择时信号。

持股人类型

Mutual Fund81.17%
Hedge Fund8.11%
Public Company4.43%
Government Pension Fund2.32%
Private Company1.28%
Sovereign Wealth Fund1.07%
Individual/Insider0.50%
Insurance Company0.36%
Family Office/Trust0.29%
Other0.48%

主要股东 截至 2026-06-30

BlackRock 10.36% · 6.53M 股
Vanguard Portfolio Management, LLC 7.74% · 4.88M 股
Dimensional Fund Advisors 5.32% · 3.36M 股
Vanguard Capital Management, LLC 5.13% · 3.24M 股
LSV Asset Management 3.59% · 2.27M 股
State Street Global Advisors 3.54% · 2.23M 股
FMR 2.42% · 1.53M 股
AQR Capital Management 2.38% · 1.50M 股
Yacktman Asset Management LP 2.33% · 1.47M 股
First Trust Advisors L.P. 2.19% · 1.38M 股

条形长度是相对于此处列出的最大股东而言,并非相对于公司100%股权。

内部人持股

共追踪50份申报 · 41次买入 · 5次卖出

姓名职务持股比例
James Zallie Chief Executive Officer 0.12%
James Gray Chief Financial Officer 0.09%
Robert Ritchie Senior VP of Food & Industrial Ingredients of America 0.05%
Larry Fernandes Senior VP and Chief Commercial & Sustainability Officer 0.04%
Eric Seip Senior VP of Global Operations & Chief Supply Chain Officer 0.04%
Jorge Alberto Uribe Lopez Independent Director 0.03%
Valdirene Evans Senior VP, President of APAC and Global Head of Pharma, Home & Beauty 0.02%
Nancy Wolfe Chief Human Resources Officer 0.02%
Tanya M. de Foras Senior VP, Chief Legal Officer, Corporate Secretary & Chief Compliance Officer 0.02%
Michael O'Riordan SVP of T&HS EMEA & Asia-Pacific 0.02%

内部人交易 最近的 Form 4 申报记录

日期姓名职务类型股数价格
2026-09-29 Eric Seip Senior VP of Global Operations & Chief Supply Chain Officer Other Derivative Acquisition +18 --
2026-09-29 Charles Magro Independent Director Other Derivative Acquisition +266 --
2026-09-14 Eric Seip Senior VP of Global Operations & Chief Supply Chain Officer Other Derivative Acquisition +17 --
2026-09-14 Michael Leonard Senior VP, Chief Innovation Officer & Head of Protein Fortification Other Derivative Acquisition +28 --
2026-08-30 Eric Seip Senior VP of Global Operations & Chief Supply Chain Officer Other Derivative Acquisition +16 --
2026-08-30 Michael Leonard Senior VP, Chief Innovation Officer & Head of Protein Fortification Other Derivative Acquisition +33 --
2026-08-13 Eric Seip Senior VP of Global Operations & Chief Supply Chain Officer Other Derivative Acquisition +16 --
2026-08-13 Michael Leonard Senior VP, Chief Innovation Officer & Head of Protein Fortification Other Derivative Acquisition +32 --
2026-08-04 David Fischer Independent Director Open Market Disposition -1,662 $102.31
2026-07-30 Eric Seip Senior VP of Global Operations & Chief Supply Chain Officer Other Derivative Acquisition +17 --
2026-07-30 Michael Leonard Senior VP, Chief Innovation Officer & Head of Protein Fortification Other Derivative Acquisition +34 --
2026-07-14 Eric Seip Senior VP of Global Operations & Chief Supply Chain Officer Other Derivative Acquisition +17 --
2026-07-14 Michael Leonard Senior VP, Chief Innovation Officer & Head of Protein Fortification Other Derivative Acquisition +34 --
2026-06-30 Kenneth Escoe Director Other Acquisition +1,516 $98.97
2026-06-29 Eric Seip Senior VP of Global Operations & Chief Supply Chain Officer Other Derivative Acquisition +18 --
2026-06-29 Charles Magro Independent Director Other Derivative Acquisition +265 --
2026-06-29 Michael Leonard Senior VP, Chief Innovation Officer & Head of Protein Fortification Other Derivative Acquisition +36 --
2026-06-14 Eric Seip Senior VP of Global Operations & Chief Supply Chain Officer Other Derivative Acquisition +17 --
2026-06-14 Michael Leonard Senior VP, Chief Innovation Officer & Head of Protein Fortification Other Derivative Acquisition +33 --
2026-05-28 Eric Seip Senior VP of Global Operations & Chief Supply Chain Officer Other Derivative Acquisition +17 --

Form 4 申报记录,每家公司显示最新的一批。"Other Derivative Acquisition"(其他衍生品获取)类目多为限制性股票/期权归属,并非公开市场买入——具体类型见"类型"列。

报价时间 2026-10-16 19:30:04 · 仅供参考,不构成投资建议,也未考虑您的具体情况。

英格雷顿 讨论区 0 条评论

发表评论